Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.90 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24547426 | 1.00 | TSHR (0.90) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL15358765 | 0.97 | TSHR (0.85) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL9447833 | 0.95 | TSHR (0.81) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL17549552 | 0.94 | TSHR (1.00) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL21272 | 0.94 | TSHR (1.00) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL13974192 | 0.94 | TSHR (1.00) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL19410576 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL262140 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL2786172 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL21834095 | 0.92 | TSHR (0.95) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 700 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104466-A1 | SELF-HEALING POLYMERS | VRIJE UNIVERSITEIT BRUSSEL (BE) | 2026-05-21 | — | — | WO | claimed |
| US-20260028505-A1 | 1,3-PROPANEDIOL ACRYLATES, DIACRYLATES, MONOACRYLATES, METHACRYLATES, AND DIGLYCIDYL ETHER AND USES THEREOF | PRIMIENT COVATION LLC (US) | 2026-01-29 | — | — | US | claimed |
| US-20240182630-A1 | RECYCLABLE AND DECOMPOSABLE EPOXY RESINS: COMPOSITIONS, PREPARATION METHODS AND APPLICATIONS IN CARBON FIBER REINFORCED COMPOSITES | SPERO RENEWABLES, LLC | 2024-06-06 | — | — | US | claimed |
| CN-117964994-A | Preparation method and recovery method of recyclable graphene nano conductive film | 滁州惠科光电科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| US-20240091150-A1 | PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-03-21 | — | — | US | claimed |
| US-20240091109-A1 | COMPOSITION COMPRISING POLYMERS OF NATURAL ORIGIN AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-03-21 | — | — | US | claimed |
| US-20240084229-A1 | DETERGENT COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-03-14 | — | — | US | claimed |
| US-20240024486-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-01-25 | — | — | US | claimed |
| US-20240026250-A1 | LIQUID DETERGENT COMPOSITION FOR HOUSEHOLD OR INDUSTRIAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-01-25 | — | — | US | claimed |
| US-20240026078-A1 | Polymer taking the form of a pulverulent solid and having properties for thickening polar media | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2024-01-25 | — | — | US | claimed |
| EP-1861346-A1 | ETHER ALCOHOL-BASED SURFACTANTS HAVING A REDUCED SURFACE TENSION AND USE THEREOF | Evonik Goldschmidt GmbH (DE) | 2007-12-05 | — | — | EP | claimed |
| US-20070175821-A1 | Selective membrane having a high fouling resistance | TORAY ADVANCED MATERIALS KOREA INC, (KR) | 2007-08-02 | — | — | US | claimed |
| WO-2006099932-A1 | ETHER ALCOHOL-BASED SURFACTANTS HAVING A REDUCED SURFACE TENSION AND USE THEREOF | GOLDSCHMIDT GESELLSCHAFT MIT BESCHRÄNKTER HAFTUNG (DE) | 2006-09-28 | — | — | WO | claimed |
| CN-1198894-C | Amino-polyether modified epoxy and cationic cataphoresis paint composition containing the epoxy | NIPPON PAINT CO LTD (JP) | 2005-04-27 | — | — | CN | claimed |
| US-20030121844-A1 | Selective membrane having a high fouling resistance | SAEHAN INDUSTRIES INCORPORATION (KR) | 2003-07-03 | — | — | US | claimed |
| CN-1368525-A | Amino-polyether modified epoxy and cationic cataphoresis paint composition containing the epoxy | NIPPON PAINT CO LTD (JP) | 2002-09-11 | — | — | CN | claimed |
| EP-0509833-B1 | An intracorporeally injectable composition for implanting highly concentrated cross-linked atelocollagen | KOKEN KK (JP) | 1996-07-17 | — | — | EP | claimed |
| US-5314874-A | Crosslinked with a polyhydroxy compound; tissue repair | KOKEN CO., LTD. (JP) | 1994-05-24 | — | — | US | claimed |
| US-5290685-A | Method for separation and concentration of phosphopeptides | MEIJI MILK PRODUCTS COMPANY LIMITED (JP) | 1994-03-01 | — | — | US | claimed |
| EP-0509833-A1 | An intracorporeally injectable composition for implanting highly concentrated cross-linked atelocollagen | KOKEN CO. LTD. (JP) | 1992-10-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240091109-A1 | COMPOSITION COMPRISING POLYMERS OF NATURAL ORIGIN AND HAVING PROPERTIES FOR THICKENING POLAR MEDIA | PHOSPHO1, GRIA1, GRM7 | TSHR 4235/4885SMN1; SMN2 1930/4885ALDH1A1 3020/4885 |
| US-20240026078-A1 | Polymer taking the form of a pulverulent solid and having properties for thickening polar media | PGAM1, GLUL, SGTA | TSHR 3936/4885SMN1; SMN2 4392/4885ALDH1A1 4362/4885 |
| US-20240024486-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT | PGA5, SGTA, GYPA | TSHR 4192/4885SMN1; SMN2 4708/4885ALDH1A1 1927/4885 |
| US-20240091150-A1 | PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES | PHOSPHO1, GYPA, SGTA | TSHR 3497/4885SMN1; SMN2 2581/4885ALDH1A1 3432/4885 |
| US-20260028505-A1 | 1,3-PROPANEDIOL ACRYLATES, DIACRYLATES, MONOACRYLATES, METHACRYLATES, AND DIGLYCIDYL ETHER AND USES THEREOF | DCLRE1A, ALG3, ICAM1 | TSHR 4794/4885SMN1; SMN2 2957/4885ALDH1A1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.